Education
About Us
Working with TipRanks
Follow Us
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -66.83K | $ -57.77K | $ -34.02K | $ -80.00K |
| Operating Income | $ -14.74K | $ -25.46M | $ -28.53M | $ -12.40M | $ -5.97M |
| EBITDA | $ -14.67K | $ -25.39M | $ -28.48M | $ -12.33M | $ -5.95M |
| Net Income | $ -13.95K | $ -24.22M | $ -27.65M | $ -12.55M | $ -5.93M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 14.27M | $ 19.78M | $ 39.89M | $ 61.16M | $ 11.70M |
| Total Assets | $ 16.96M | $ 22.15M | $ 43.06M | $ 64.35M | $ 12.48M |
| Total Debt | $ 324.00K | $ 392.00K | $ 214.00K | $ 343.00K | $ 428.00K |
| Net Debt | $ -5.75M | $ -8.90M | $ -13.30M | $ -14.34M | $ -11.25M |
| Total Liabilities | $ 3.43M | $ 5.15M | $ 6.84M | $ 2.89M | $ 1.67M |
| Stockholders' Equity | $ 13.54M | $ 17.00M | $ 36.22M | $ 61.47M | $ 10.80M |
| Cash Flow | |||||
| Free Cash Flow | $ 0.00 | $ -23.61M | $ -20.44M | $ -12.61M | $ -5.28M |
| Operating Cash Flow | $ 0.00 | $ -23.61M | $ -20.37M | $ -12.37M | $ -5.24M |
| Investing Cash Flow | $ 0.00 | $ 15.88M | $ 19.53M | $ -45.19M | $ -62.00K |
| Financing Cash Flow | $ 0.00 | $ 3.50M | $ -808.00K | $ 61.07M | $ 4.75M |